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OBJECTIVE—We examined the relationship between the presence and extent of coronary
stenosisandcarotidintima-mediathickness(CIMT)intype2diabeticpatientswithouthistoryof
coronary artery disease (CAD) but with carotid atherosclerosis.
RESEARCH DESIGN AND METHODS—A total of 91 type 2 diabetic patients under-
went multi-slice computed tomography coronary angiography.
RESULTS—Max-IMT in the $50% stenosis group by multi-slice computed tomography cor-
onary angiography estimation was signiﬁcantly greater than the 0–25 and 25–50% stenosis
group (2.68 6 0.77 vs. 1.61 6 0.49 mm, P , 0.0005, and 2.14 6 0.81 mm, P , 0.05, re-
spectively),andmax-IMTinthe25–50%stenosisgroupwassigniﬁcantlygreaterthanthe0–25%
stenosisgroup(P,0.05)afteradjustmentforage,sex,durationoftype2diabetes,hypertension,
and dyslipidemia. In the analysis for trend through the categories of max-IMT, as max-IMT
increased, the percentage of $50% stenosis increased and the percentage of 0–25% stenosis
decreased.
CONCLUSIONS—Our data suggest that max-IMT might be closely associated with the ex-
tent of coronary stenosis in type 2 diabetic patients without history of CAD but with carotid
atherosclerosis.
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C
oronary stenosis was evaluated with
selective coronary angiography, but
the subjects were limited to patients
with a history and/or suspicion of coro-
nary artery disease (CAD) because of its
invasiveness.Therefore, littleinformation
is available regarding the relationship
between coronary stenosis and carotid
intima-media thickness (CIMT) in asymp-
tomatic type 2 diabetic patients. Recently,
multi-slicecomputedtomography(MSCT)
coronary angiography (MSCTA) enabled
us to evaluate coronary stenosis accurately
and noninvasively (1–3).
In this study, we performed MSCTA
in patients without a history of CAD but
with carotid atherosclerosis and explored
the usefulness of CIMT measurement in
screening for CAD in asymptomatic type
2 diabetic patients for which a useful
strategy remains uncertain and contro-
versial (4–8).
RESEARCH DESIGN AND
METHODS
Study population
Among 169 type 2 diabetic inpatients in
Osaka University MedicalHospitalwhose
max-IMT was $1.1 mm and who did not
have a history of CAD, which was de-
ﬁned as documentation of medication
and history of myocardial infarction, an-
gina pectoris, and/or previous coronary
intervention, 91 patients consented to
undergo MSCTA. The clinical character-
istics of the subjects were as follows: men
67%; age 62 6 10 years; duration of type
2d i a b e t e s1 36 9 years; smoking 56%
(deﬁnition of smoking was based on a
questionnaire); hypertension 56%; dys-
lipidemia 76%; A1C 8.3 6 1.7%; max-
IMT 2.17 6 0.83 mm; ankle-brachial
pressure index (ABPI) 1.07 6 0.14; and
brachial-anklepulsewavevelocity(baPWV)
1,770 6 394 (cm/s).
CIMT measurement
CIMT was measured using an echoto-
mographic system (Aplio AAS-700A;
Toshiba MedicalSystems,Tochigi,Japan)
with a 7.5-MHz linear transducer. With
the longitudinal projection of the com-
mon carotid artery, the carotid bulb, and
the internal carotid artery, the site of the
greatest thickness including a plaque
lesion was sought along both near and
far walls bilaterally (max-IMT). Carotid
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BRIEF REPORTatherosclerosis was deﬁned as max-IMT
$1.1 mm according to the criteria of the
Japan Academy of Neurosonology (9). In
addition, all measurements of CIMT were
performed by experienced physicians.
MSCT coronary angiography
Imaging was performed with a 64-slice
(indicated as (64) hereafter) or 320-slice
(likewise indicated as (320)) MSCT scan-
ner (Aquilion (64) or Aquilion ONE
(320);ToshibaMedicalSystems).MSCTA
was performed with a helical (64) or
volumetric (320) scan with b-blockers
and sublingual nitrates if necessary. Re-
construction with phases of fewest mo-
tion artifacts was performed and images
were transferred to a remote workstation
for post-processing.
MSCTAimageswereinterpretedbytwo
experienced observers blind to the patient’s
characteristics using specialized software
(Ziostation; Ziosoft, Tokyo, Japan).
Using a 15-segment model according
to the American Heart Association classi-
ﬁcation, presence of coronary athero-
sclerosis and luminal narrowing in each
segment was visually graded into four
classes: 0–25% stenosis, 25–50% steno-
sis,50–75%stenosis,and$75%stenosis.
Statistical analysis
Max-IMT was compared by ANCOVA
with Holm adjustments. Analysis of trend
through categories of max-IMT was per-
formed with the x
2 test for trend. The re-
ceiver operating characteristic (ROC)
curve analysis was used to determine the
optimal cutoff value of max-IMT for
$50% coronary stenosis. CIs of ROC val-
ues were calculated through bootstrap re-
sampling,andtherewere2,000bootstrap
samples, according to the percentile
method. The threshold of statistical sig-
niﬁcance was deﬁned as P , 0.05.
RESULTS
MSCTA results
A total of 1,330 coronary segments were
analyzed, and 17 were undiagnosable
becauseofmotion(n=12)orcalciﬁcation
(n=5).Atotalof29 patients (32%) had at
least one segment of $50% stenosis, 37
(41%) had at least one segment of
25–50% stenosis, and 25 (27%) had
only 0–25% stenosis.
Relationship between CIMT and
coronary stenosis
Max-IMT was signiﬁcantly greater in the
$50% stenosis group (2.68 6 0.77 mm)
comparedwith the0–25%stenosisgroup
(1.61 6 0.49 mm) (P , 0.0005) and the
25–50% stenosis group (2.14 6 0.81
mm) (P , 0.05), and the max-IMT of
the 25–50% stenosis group was signiﬁ-
cantly greater than the 0–25% stenosis
group (P , 0.05) after adjustment for
age, sex, duration of type 2 diabetes, hy-
pertension, and dyslipidemia (Fig. 1A).
In the analysis for trend through
the categories of max-IMT, as max-IMT
increased, the percentage of $50% ste-
nosisincreased(P,0.00005)andtheper-
centage of 0–25% stenosis decreased
(P , 0.0001) (Fig. 1B).
ROC curve analysis for $50%
stenosis
The area under the ROC curve (AUC) of
max-IMT, ABPI, and baPWV were 0.78
(95% CI 0.70–0.86), 0.72 (0.63–0.83),
and 0.73 (0.62–0.83), respectively. The
Figure 1—A:The relationshipbetween CIMTand coronarystenosis. Max-IMTwassigniﬁcantly
greater in the $50% stenosis group (2.68 6 0.77 mm) than the 0–25% stenosis group (1.61 6
0.49 mm) (P , 0.0005) and the 25–50% stenosis group (2.14 6 0.81 mm) (P , 0.05). In ad-
dition, the max-IMT of the 25–50% stenosis group was signiﬁcantly greater than the 0–25%
stenosis group (P , 0.05). B: The extent of coronary stenosis in each max-IMT category. In
the max-IMT ,1.6 mm group, the percentage of $50% stenosis was 0%, whereas in the patients
whose max-IMT was $1.6 mm, the percentage of $50% stenosis was 45%. Furthermore, in the
analysis for trend through the categories of max-IMT, as max-IMT was increased,the percentage
of $50% stenosis was increased (P , 0.00005) and the percentage of 0–25% stenosis was de-
creased (P , 0.0001).
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Kasami and Associatescutoff level of max-IMT providing the
maximal sum of sensitivity and speciﬁcity
w a s1 . 9 0m m( 9 5 %C I1 . 6 –2.5). At this
cutofflevel,sensitivitywas0.93(95%CI
0.71–1.00) and speciﬁcity was 0.55
(0.42–0.83). The positive predictive value
was 0.49 (95% CI 0.39–0.69), and the neg-
ative predictive value was 0.94 (0.84–1.00).
When max-IMT was combined with
baPWV and ABPI, the AUC of max-IMT
was 0.83 (95% CI 0.75–0.92) at a max-
IMT cutoff level of 1.60 mm (1.6–2.1), a
baPWV cutoff level of 1,430 cm/s, and an
ABPI cutoff level of 1.19. At these cutoff
values,sensitivitywas0.97(95%CI0.87–
1.00)andspeciﬁcity was 0.68(0.60–0.83).
Positive predictive value was 0.58 (95% CI
0.49–0.75), and negative predictive value
was 0.98 (0.92–1.00).
CONCLUSIONS—Our data suggest
that max-IMT might be closely associated
with the presence and extent of coronary
stenosis in type 2 diabetic patients with-
out history of CAD but with carotid
atherosclerosis and that max-IMT mea-
surement might have a passable AUC,
high sensitivity, high negative predictive
value, low speciﬁcity, and low positive
predictive value for signiﬁcant coronary
stenosis. We propose a hypothesis that
max-IMT measurement might be useful
for distinguishing patients who need not
undergo workup for coronary stenosis
but thatmax-IMT might beinsufﬁcientto
determine patients who should undergo
workup for coronary stenosis. We con-
sider this study not conclusive but hy-
pothesis generating. When this study was
designed, available information was so
little to calculate an appropriate sample
size. Consequently, our study population
of 91 was insufﬁcient to calculate clini-
cally useful cutoff values with narrower
95% CIs and to compare usefulness of
max-IMT, ABPI, and baPWV. Another
limitation of this study was CIMT mea-
surements, which were performed by
three operators as daily clinical routine
examinations and should inevitably in-
volve operator variability. Larger replica-
tion studies need to be designed with
appropriate sample size calculations, and
our results may provide a rationale to
conduct such studies.
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